A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies.
Journal Information
Full Title: Gene Ther
Abbreviation: Gene Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Genetics, Medical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests OD, DA, DT, MD, AP, and BKT are employees of Novartis Gene Therapies, Inc., and own stock/other equities. SS and MT have received consulting fees from Novartis Gene Therapies, Inc., for this research. SDS has received research grants and consulting fees from Novartis Gene Therapies, Inc., and served as consultant/on an advisory board for Bayer US. ST has received honoraria from Novartis Gene Therapies, Inc. He has also received payment for participation on a BioMarin advisory board and participated in a scientific advisory board meeting for UCB Pharma."
"Funding This study was funded by Novartis Gene Therapies, Inc."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025